CONDITION

Chronic Pancreatitis

Chronic pancreatitis describes ongoing inflammation in the pancreas that persists or recurs over time. The pancreas sits near the stomach and small intestine, producing enzymes that help digest food and hormones that regulate blood sugar. When inflammation becomes a long-term pattern, the normal tissue can be gradually replaced by scar tissue, which may affect how well the organ works. Owners often arrive at this page because their dog or cat has had repeated episodes of digestive upset—vomiting, reduced appetite, weight loss, or abdominal discomfort—that seem to settle and then return. In cats particularly, the signs can be subtle and build slowly over months. The condition can exist on its own or alongside other problems affecting the liver or intestines. This page explores the signals that may suggest chronic pancreatitis, what is happening in the tissue over time, how the condition is investigated through blood tests and imaging, and the range of approaches used to manage it. The goal is to help you understand what this diagnosis means and what shape care may take.

Why this matters now

Chronic pancreatitis can appear at any age, though it tends to be recognised more often in middle-aged and older animals. In cats, the condition is seen across many breeds and mixed-breed populations, often developing quietly over months or years. In dogs, certain breeds—including Miniature Schnauzers, Cocker Spaniels, and some terrier types—appear more prone, and repeated episodes may follow dietary indiscretions or metabolic disturbances. The condition can also emerge alongside other inflammatory problems affecting the liver or intestines, particularly in cats.

The pattern is typically one of slow, fluctuating change rather than a single crisis. Some animals experience intermittent flare-ups separated by weeks or months of relative calm, while others show a more gradual decline in appetite, weight, and energy. Over time, repeated inflammation can lead to permanent scarring and reduced function, though the rate and extent of this damage varies widely between individuals. The course is often unpredictable, and periods of stability can be interrupted by setbacks that may or may not have an obvious trigger.

Signals & patterns

Early signals

Intermittent reduced appetite

The animal may eat normally for days or weeks, then become less interested in food for a stretch before recovering. This waxing and waning pattern can be subtle, especially in cats, who may simply spend longer at the bowl or eat smaller portions without refusing food outright.

Occasional vomiting

Vomiting may occur once or twice over several days, then disappear for a period. The episodes may not follow a clear pattern and can be mistaken for hairballs or minor dietary upset, particularly if the animal otherwise seems well.

Quiet abdominal discomfort

Some animals adopt a hunched posture, avoid being picked up around the middle, or seem restless after eating. In cats, discomfort is often expressed through withdrawal or a reluctance to jump rather than obvious signs of pain.

Gradual weight loss

Weight may drop slowly over weeks or months, often noticed only when comparing the feel of the ribs or spine to earlier photos. The change can be masked by a normal coat or the animal's usual body shape, making it easy to overlook until it becomes pronounced.

Softer or variable stools

Faeces may become less formed or change consistency from day to day, though diarrhoea is not always present. The variation may coincide with periods of reduced appetite or vomiting, or it may appear on its own.

Later signals

Persistent poor appetite

The animal may show little interest in food for days at a time, or eat only small amounts despite encouragement. This can progress to near-total refusal, particularly in cats, where prolonged inappetence carries additional metabolic risks.

Visible weight loss and muscle wasting

Loss of body condition becomes obvious along the spine, hips, and shoulders. Muscle over the skull and limbs may also diminish, giving the animal a gaunt appearance even if the coat remains in reasonable condition.

Ongoing digestive upset

Vomiting, diarrhoea, or both may occur more frequently and with less respite between episodes. The animal may also show signs of nausea—drooling, lip-licking, or reluctance to move—without necessarily vomiting.

Low energy and withdrawal

The animal may spend more time resting, show less interest in play or interaction, and move more slowly. In cats, this can include hiding more often or choosing spots that are quieter and less accessible than usual.

Click to read about the biological mechanisms

How this is usually investigated

Investigating chronic pancreatitis typically begins with a detailed history of how the signs have evolved over time, including the pattern of any flare-ups and periods of relative calm. Physical examination may reveal abdominal discomfort or weight loss, though many animals show few outward signs between episodes. Laboratory tests and imaging are then used to look for evidence of ongoing inflammation, changes in pancreatic structure, and effects on digestion or blood sugar regulation.

Blood biochemistry

Purpose: This measures enzymes and proteins released by the pancreas, as well as markers of liver and kidney function. Elevated levels of certain enzymes can suggest active inflammation, though they may also rise in other conditions affecting the abdomen.
Considerations: Results can be normal even when chronic inflammation is present, particularly in cats or between flare-ups. The pattern of results over time may be more informative than a single snapshot.

Pancreatic lipase immunoreactivity (fPLI or cPLI)

Purpose: This blood test measures a specific enzyme produced by the pancreas and is more sensitive for detecting pancreatic inflammation than general biochemistry. Elevated levels can support a diagnosis of pancreatitis, though they do not distinguish between acute and chronic forms.
Considerations: The test can occasionally be elevated in animals without pancreatitis, and normal results do not rule out the condition if signs are subtle or intermittent. It is most useful when combined with other findings.

Abdominal ultrasound

Purpose: Ultrasound allows direct visualisation of the pancreas, looking for changes in size, texture, or the presence of irregular or thickened areas that suggest fibrosis. It can also reveal fluid around the organ or changes in nearby structures such as the bile duct or small intestine.
Considerations: The pancreas can be difficult to see clearly in some animals, particularly if there is abdominal gas or the organ appears relatively normal in size. Subtle changes may be missed, and the appearance does not always correlate with the severity of signs.

Serum trypsin-like immunoreactivity (TLI)

Purpose: This blood test measures circulating trypsinogen released by the pancreas and is the preferred method for assessing exocrine function, in contrast to faecal elastase testing, which has proven unreliable in dogs and cats. A low value confirms exocrine pancreatic insufficiency, a condition in which the organ no longer produces enough enzymes to digest food properly.
Considerations: This blood test is the preferred method for confirming exocrine pancreatic insufficiency in dogs and cats. Faecal elastase testing, though used in humans, has not proven reliable in dogs and cats and is not used in standard veterinary practice for this purpose.

Fine-needle aspiration or biopsy

Purpose: Sampling pancreatic tissue allows examination of the cells and structure under a microscope, confirming the presence and type of inflammation and the extent of fibrosis. This is the most definitive way to establish a diagnosis of chronic pancreatitis.
Considerations: The procedure carries some risk, including bleeding or worsening inflammation, and is usually reserved for cases where the diagnosis remains unclear despite other tests or where cancer is a concern. Results may vary depending on which part of the organ is sampled.

Options & trade-offs

Management of chronic pancreatitis is typically tailored to the individual animal and the pattern of signs they show. Most approaches combine dietary adjustment, medication to control inflammation or nausea, and monitoring for complications such as impaired digestion or blood sugar regulation. What works well for one animal may be less tolerated or less effective in another, and finding a workable combination often involves some trial and refinement over time.

Dietary modification

This involves selecting foods that are easily digestible and relatively low in fat, which may reduce the workload on the pancreas and lessen the likelihood of flare-ups. In some cases, small, frequent meals are used instead of larger portions, and novel or hydrolysed protein sources may be tried if concurrent inflammatory bowel disease is suspected. The choice of food can be adjusted based on how the animal responds over weeks to months.

Trade-offs: Not all animals tolerate the same foods, and some may refuse diets that are very bland or unfamiliar. The response can be gradual, and it may take several weeks to judge whether a particular food is helping. Dietary change alone may not control signs if inflammation is severe or if other organs are involved.

Anti-nausea and gastroprotective medication

Drugs that reduce nausea or protect the stomach lining can improve appetite and comfort, particularly during flare-ups. These medications do not address the underlying inflammation but can make the animal more willing to eat and less likely to vomit, which supports better nutritional intake and quality of life.

Trade-offs: The effect is symptomatic rather than curative, and signs may return if the medication is stopped or if inflammation worsens. Some animals require long-term use, and tolerance or side effects can develop over time.

Corticosteroids or other immunosuppressive drugs

In some animals, particularly cats with concurrent inflammatory disease elsewhere in the abdomen, corticosteroids or other drugs that dampen immune activity may reduce the severity and frequency of flare-ups. The dose is usually adjusted based on response, with the aim of using the lowest amount that keeps signs manageable.

Trade-offs: These drugs can have wide-ranging effects on the body, including increased thirst and appetite, weight gain, and changes in behaviour. Long-term use carries a risk of side effects such as thinning of the skin, increased infection risk, or worsening of blood sugar control, and not all animals respond well. Regular monitoring is often needed.

Pancreatic enzyme supplementation

If the pancreas has lost much of its ability to produce digestive enzymes, powdered or capsule enzyme supplements can be added to food to help break down fats and proteins. This is most relevant in animals showing signs of poor digestion, such as weight loss despite a good appetite or pale, greasy stools.

Trade-offs: Supplementation is lifelong once started, and the dose may need adjustment based on stool quality and weight trends. Some animals dislike the taste or texture of the powder mixed into food, and it can be impractical for owners who feed multiple pets or use certain feeding routines.

Analgesic medication

Pain relief can be given during flare-ups when abdominal discomfort is apparent, using drugs that range from mild anti-inflammatories to stronger opioid-type medications depending on the severity. The goal is to keep the animal comfortable enough to eat and rest, which supports recovery.

Trade-offs: Pain in cats can be particularly difficult to recognise and assess, and some pain relief medications carry risks to the kidneys or stomach lining, especially if used long-term or in animals with other health problems. The need for pain relief tends to fluctuate with disease activity.

Common misconceptions

Misconception:

"Once chronic pancreatitis is diagnosed, the condition will inevitably progress to complete organ failure."

Reality:

The course of chronic pancreatitis varies widely between individuals. Some animals experience intermittent flare-ups but maintain stable function for years, while others develop progressive scarring and loss of enzyme or hormone production. The rate and extent of deterioration depend on many factors, including the underlying cause, how well signs are managed, and whether other organs are involved.

Misconception:

"A strict low-fat diet is the only way to prevent flare-ups in all animals with chronic pancreatitis."

Reality:

While reducing dietary fat can help some animals, particularly dogs prone to fat-induced inflammation, others tolerate moderate fat levels without difficulty. Cats in particular may do better with diets that are simply highly digestible rather than strictly low in fat, and palatability often matters more than strict macronutrient composition. The response to diet is individual, and what works for one animal may not suit another.

Misconception:

"If blood tests and scans are normal, the animal cannot have chronic pancreatitis."

Reality:

Chronic pancreatitis can exist even when test results appear unremarkable, particularly between flare-ups or in cases where the changes are subtle or localised to a small part of the organ. The diagnosis often rests on the pattern of signs over time and the response to management, rather than a single definitive test result.

Related conditions

Acute Pancreatitis

Acute pancreatitis describes sudden inflammation of the pancreas, and in some animals repeated acute episodes can evolve into the persistent pattern seen in chronic pancreatitis. The two conditions exist on a spectrum, though not every acute episode leads to chronic change.

Triaditis in Cats

Triaditis describes simultaneous inflammation of the pancreas, liver, and small intestine, a pattern seen particularly in cats. Chronic pancreatitis can occur as part of this triad, reflecting the anatomical proximity and shared drainage pathways of these organs.

Cholangiohepatitis in Cats

Cholangiohepatitis involves inflammation of the bile ducts and liver tissue, and in cats it can occur alongside chronic pancreatitis due to the close anatomical relationship between the pancreatic duct and the bile system. The two conditions may share underlying inflammatory triggers.

Lymphoplasmacytic Enteritis

Lymphoplasmacytic enteritis describes persistent inflammation in the small intestine, and it can occur together with chronic pancreatitis, particularly in cats. Both conditions may reflect broader immune or inflammatory processes affecting neighbouring digestive organs.

Protein-Losing Enteropathy

Protein-losing enteropathy can develop when chronic inflammation in the intestines causes loss of protein into the gut, and chronic pancreatitis may contribute to this pattern by affecting digestive enzyme secretion and intestinal health over time.

If chronic pancreatitis has been discussed, it may be useful to understand how the pancreas relates to other aspects of metabolic health, including blood sugar regulation and the digestion of nutrients. In cats, exploring the links between pancreatitis, liver inflammation, and inflammatory bowel disease can offer context for why multiple systems may be affected at once. Conversations about monitoring, adjusting management over time, and recognising early signs of a flare-up can help shape the ongoing care of an animal living with this condition.